Table 1 Comparison of demographic criteria of overseas commercial transplanted (Group I) and locally transplanted (Group II) groups
From: Navigating risks: insights on unrelated overseas renal transplantations from two Saudi centers
Group I No = 96 | Group II No = 108 | p-value | |
|---|---|---|---|
Age.Mean ± SD. Yrs.* | 54.3 ± S16.6 | 48.7 ± 16.2 | 0.01 |
Gender** Male Female | 64 (66.6%) 32 (33.3%) | 67 (62%) 41 (38%) | 0.4 |
BMI.Mean ± SD.Kg/m2* | 29 ± 3.8 | 27 ± 4.4 | 0.001 |
Cause of renal failure** Diabetes Hypertension Both Polycystic kidney disease Others | 21 (21.8%) 52 (54.2%) 17 (17.8%) 1 (1%) 5 (5.2%) | 26 (24%) 58 (54%) 18 (16.5%) 4(3.7%) 2(1.8%) | 0.4 |
Type of Dialysis** HD PD | 94 (98%) 2 (2%) | 106 (98%) 2 (2%) | 0.9 |
Duration of dialysis # Median (IQR). Yrs | 3 (2–4) | 2 (1–4) | 0.9 |
Transplantation number** First transplantation Second transplantation | 96(100%) 0 | 104(96.3%) 4(3.7%) | 0.1 |
Induction Immunosuppression** Basiliximab ATG Unknown | 60(62.5%) 25 (26%) 11(11.5%) | 103 (95.3%) 5 (4.7%) 0 | 0.01 |
30-days hospital stay. Mean ± SD. Days* | 9.4 ± 1.6 | 7.9 ± 1 | < 0.001 |
Graft Function** Primary functioning graft (PFG) Slow Graft Function (SGF) Delayed Graft Function (DGF) | 80(83.3%) 6(6.3%) 10(10.4%) | 101 (93.5%) 6(5.6%) 1(0.9%) | 0.01 |
Follow-up duration # Median (IQR). Mo | 38(14–51) | 40 (29–52) | 0.8 |